SZSE:000999 (China)
Â
Class A
Â¥
64.65
(+0.02%)
Jun 7
Current and historical daily PE Ratio for China Resources Sanjiu Medical & Pharmaceutical Co Ltd (
SZSE:000999
) from 2000 to Jun 07 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. China Resourcesnjiu Medical & Pharmaceutical stock (SZSE:000999) PE ratio as of Jun 07 2024 is 20.65.
More Details
China Resources Sanjiu Medical & Pharmaceutical Co Ltd (SZSE:000999) PE Ratio (TTM) Chart
China Resources Sanjiu Medical & Pharmaceutical Co Ltd (SZSE:000999) PE Ratio (TTM) Historical Data
View and export this data going back to 2000. Start your Free Trial
Total 1205
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| China Resourcesnjiu Medical & Pharmaceutical PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-07 | 20.6 | 2024-04-03 | 16.2 |
| 2024-06-06 | 20.6 | 2024-04-02 | 16.2 |
| 2024-06-05 | 20.4 | 2024-04-01 | 16.7 |
| 2024-06-04 | 20.4 | 2024-03-29 | 16.6 |
| 2024-06-03 | 19.8 | 2024-03-28 | 16.9 |
| 2024-05-31 | 19.4 | 2024-03-27 | 18.3 |
| 2024-05-30 | 19.5 | 2024-03-26 | 18.0 |
| 2024-05-29 | 19.9 | 2024-03-25 | 17.9 |
| 2024-05-28 | 20.1 | 2024-03-22 | 18.8 |
| 2024-05-27 | 20.0 | 2024-03-21 | 18.6 |
| 2024-05-24 | 19.4 | 2024-03-20 | 18.6 |
| 2024-05-23 | 19.1 | 2024-03-19 | 18.5 |
| 2024-05-22 | 19.1 | 2024-03-18 | 18.3 |
| 2024-05-21 | 19.7 | 2024-03-15 | 18.4 |
| 2024-05-20 | 20.0 | 2024-03-14 | 18.6 |
| 2024-05-17 | 19.7 | 2024-03-13 | 18.4 |
| 2024-05-16 | 20.3 | 2024-03-12 | 18.9 |
| 2024-05-15 | 20.4 | 2024-03-11 | 18.8 |
| 2024-05-14 | 20.2 | 2024-03-08 | 18.6 |
| 2024-05-13 | 20.3 | 2024-03-07 | 18.5 |
| 2024-05-10 | 19.5 | 2024-03-06 | 19.1 |
| 2024-05-09 | 19.4 | 2024-03-05 | 19.4 |
| 2024-05-08 | 19.5 | 2024-03-04 | 18.9 |
| 2024-05-07 | 19.3 | 2024-03-01 | 18.7 |
| 2024-05-06 | 19.4 | 2024-02-29 | 19.0 |
| 2024-05-03 | 19.2 | 2024-02-28 | 18.6 |
| 2024-05-02 | 19.2 | 2024-02-27 | 18.7 |
| 2024-04-30 | 19.2 | 2024-02-26 | 18.5 |
| 2024-04-29 | 18.9 | 2024-02-23 | 19.0 |
| 2024-04-26 | 19.4 | 2024-02-22 | 19.2 |
| 2024-04-25 | 19.3 | 2024-02-21 | 19.3 |
| 2024-04-24 | 18.8 | 2024-02-20 | 19.6 |
| 2024-04-23 | 19.1 | 2024-02-19 | 19.0 |
| 2024-04-22 | 19.2 | 2024-02-16 | 19.4 |
| 2024-04-19 | 18.9 | 2024-02-09 | 19.4 |
| 2024-04-18 | 18.5 | 2024-02-08 | 19.4 |
| 2024-04-17 | 18.4 | 2024-02-07 | 20.1 |
| 2024-04-16 | 18.1 | 2024-02-06 | 19.2 |
| 2024-04-15 | 18.1 | 2024-02-05 | 19.5 |
| 2024-04-12 | 17.5 | 2024-02-02 | 18.9 |
| 2024-04-11 | 17.6 | 2024-02-01 | 18.8 |
| 2024-04-10 | 16.9 | 2024-01-31 | 18.0 |
| 2024-04-09 | 16.7 | 2024-01-30 | 18.6 |
| 2024-04-08 | 16.3 | 2024-01-29 | 19.6 |
| 2024-04-05 | 16.2 | 2024-01-26 | 19.2 |
China Resources Sanjiu Medical & Pharmaceutical Co Ltd (SZSE:000999) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
NAICS : 325199
SIC : 2834
ISIN : CNE0000011K8
Share Class Description:
SZSE:000999: Class ACompare
Compare
Traded in other countries / regions
000999.China IPO Date
2000-03-09Description
China Resources Sanjiu Medical & Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in the research and development, production and sale of pharmaceutical products, healthcare products, and medical appliances under the brand name 999, which includes OTC, antibiotic and raw material drug. The other brands under which the company offers its products are Lee King, Shunfeng, and Tianhe. The company's core business is located in OTC and Chinese medicine prescription drugs, OTC core products in the cold, gastrointestinal, skin, pediatric, cough and orthopedic drugs occupy a higher market share; prescription drug products in traditional Chinese medicine formula granules, cardiovascular and cerebrovascular, anti-tumor in the field of anti-infection and other areas.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers